Literature DB >> 3177306

Necrotizing tracheobronchitis. An ischemic lesion.

J B Hanson1, G Waldstein, J A Hernandez, L L Fan.   

Abstract

Neonates with necrotizing tracheobronchitis present a diverse clinical spectrum from asymptomatic disease to severe airway obstruction. A retrospective clinicopathologic study of 206 neonatal autopsy reports spanning a three-year period yielded 122 cases of necrotizing tracheobronchitis with an incidence of 59%. All study patients received treatment prior to the development of high-frequency ventilator jet, oscillator, or interruption. The site and submucosal depth of airway involvement was variable. The most commonly affected anatomic site was the middle or thoracic trachea (56%). The common cause identified was severe ischemia to the airway mucosa and submucosa, occurring with profound birth asphyxia and/or shock. The presence of ischemia supports the concept that decreased tracheoperfusion may be an important factor in the development of tracheobronchial abnormalities.

Entities:  

Mesh:

Year:  1988        PMID: 3177306     DOI: 10.1001/archpedi.1988.02150100088034

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  4 in total

Review 1.  Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy.

Authors:  H Kono; S Inokuma; H Nakayama; M Suzuki
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

2.  Tracheobronchomegaly in preterm infants on mechanical ventilation.

Authors:  Z Zupancic; J Primozic
Journal:  Pediatr Radiol       Date:  1995

3.  A new prototype of an electronic jet-ventilator and its humidification system.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

4.  Single-cell lineage analysis reveals extensive multimodal transcriptional control during directed beta-cell differentiation.

Authors:  Chen Weng; Jiajia Xi; Haiyan Li; Jian Cui; Anniya Gu; Sisi Lai; Konstantin Leskov; Luxin Ke; Fulai Jin; Yan Li
Journal:  Nat Metab       Date:  2020-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.